Bioceres Seeks Nasdaq Extension to Avoid Delisting

Bioceres Crop Solutions Corp. is set to receive a 180-day extension from Nasdaq to regain the minimum bid price of $1 per share and avoid delisting, according to a person familiar with the matter. The initial deadline expired on 14 September. Nasdaq declined to comment to Bloomberg Línea on the extension request.

To regain compliance, the company's shares must close at $1 or higher for at least 10 consecutive trading days, a benchmark not achieved in six months. Bioceres traded around $0.42 on Friday. If it fails to meet the threshold within 180 days, the company may consider a reverse stock split.

The price slump follows legal and financial challenges tied to its 2022 acquisition of Marrone Bio Innovations, later renamed Pro Farm. Bioceres issued $55 million in secured debt for the deal. In June 2026, the New York State Supreme Court ruled against Bioceres over loan defaults. Creditors led by Jasper Lake Ventures, which holds a 13.72% equity stake in Bioceres, acquired Pro Farm at a foreclosure auction for $15 million against a book value near $194 million, generating an accounting loss of about $179 million for Bioceres. Meanwhile, Argentine entity Bioceres S.A. was declared bankrupt in Rosario in March.

Between January and March 2026, Bioceres reported revenue of $39.4 million, down 23% year over year, alongside a net loss of $10 million. The company ended the period with total financial debt of $228.8 million and cash of $14.4 million. As of 11 September, 303 of the 3,361 common stocks and primary listings on Nasdaq, or nearly 9%, traded below the $1 threshold.